GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) » Definitions » Research & Development

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Research & Development : ¥317 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Jiuzhou Pharmaceutical Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Zhejiang Jiuzhou Pharmaceutical Co's Research & Development for the three months ended in Mar. 2024 was ¥65 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥317 Mil.


Zhejiang Jiuzhou Pharmaceutical Co Research & Development Historical Data

The historical data trend for Zhejiang Jiuzhou Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jiuzhou Pharmaceutical Co Research & Development Chart

Zhejiang Jiuzhou Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.50 114.23 173.36 287.38 330.83

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78.77 88.26 72.81 90.99 64.87

Zhejiang Jiuzhou Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥317 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Jiuzhou Pharmaceutical Co  (SHSE:603456) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Zhejiang Jiuzhou Pharmaceutical Co Research & Development Related Terms

Thank you for viewing the detailed overview of Zhejiang Jiuzhou Pharmaceutical Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Business Description

Traded in Other Exchanges
N/A
Address
99 Waisha Road, Jiaojiang District, Taizhou, Zhejiang, CHN, 318000
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.
Executives
Sha Yu Jie Directors, senior managers
Mei Yi Jiang Director
Li Yuan Qiang senior management
Yang Nong Gang senior management
Directors, senior managers
Huang Min Xia senior management
Wang Bin Directors, senior managers
Dai Yun You senior management
Jiang Zu Lin Directors, senior managers
Guo Zhen Rong senior management
Chen Zhi Hong Directors, senior managers
Xu Jia Jun Supervisors
Hua Li Rong Director
Lin Hui Lu senior management
Zhu Guo Liang Supervisors

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Headlines

No Headlines